{
    "ticker": "GCTS.WS",
    "name": "Genetic Technologies Limited",
    "description": "Genetic Technologies Limited is a biotechnology company that specializes in providing innovative genetic testing solutions. Founded in 1989 and headquartered in Melbourne, Australia, the company focuses on developing and commercializing advanced genetic tests that help healthcare professionals and patients make informed decisions about health management and disease prevention. Genetic Technologies is particularly known for its proprietary gene testing technology, which offers insights into a variety of health conditions, including cancer risk and inherited diseases. The company aims to improve patient outcomes through early detection and personalized medicine. With a commitment to research and development, Genetic Technologies continues to expand its product offerings and enhance its testing capabilities, striving to be at the forefront of the growing field of genetic diagnostics. Their tests are designed to be user-friendly, allowing patients to easily access their genetic information and understand their health risks. Genetic Technologies is also actively involved in partnerships and collaborations with healthcare providers, research institutions, and industry leaders to advance the field of genetic testing and expand accessibility to innovative healthcare solutions.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Melbourne, Australia",
    "founded": "1989",
    "website": "https://www.genetictechnologies.com.au",
    "ceo": "John R. A. R. DeGroot",
    "social_media": {
        "linkedin": "https://www.linkedin.com/company/genetic-technologies-limited/"
    },
    "investor_relations": "https://www.genetictechnologies.com.au/investors",
    "key_executives": [
        {
            "name": "John R. A. R. DeGroot",
            "position": "CEO"
        },
        {
            "name": "Danielle T. DeGroot",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genetic Testing",
            "products": [
                "Cancer Risk Tests",
                "Inherited Disease Tests"
            ]
        }
    ],
    "seo": {
        "meta_title": "Genetic Technologies Limited | Innovative Genetic Testing Solutions",
        "meta_description": "Explore Genetic Technologies Limited, a leader in biotechnology and genetic testing. Learn about our innovative products and commitment to improving healthcare.",
        "keywords": [
            "Genetic Technologies",
            "Genetic Testing",
            "Biotechnology",
            "Healthcare",
            "Personalized Medicine"
        ]
    },
    "faq": [
        {
            "question": "What does Genetic Technologies specialize in?",
            "answer": "Genetic Technologies specializes in innovative genetic testing solutions for health management and disease prevention."
        },
        {
            "question": "Who is the CEO of Genetic Technologies?",
            "answer": "John R. A. R. DeGroot is the CEO of Genetic Technologies Limited."
        },
        {
            "question": "Where is Genetic Technologies headquartered?",
            "answer": "Genetic Technologies is headquartered in Melbourne, Australia."
        },
        {
            "question": "What are the main products of Genetic Technologies?",
            "answer": "The main products include cancer risk tests and inherited disease tests."
        },
        {
            "question": "When was Genetic Technologies founded?",
            "answer": "Genetic Technologies was founded in 1989."
        }
    ],
    "competitors": [
        "NTRA",
        "ILMN",
        "EXAS"
    ],
    "related_stocks": [
        "QGEN",
        "RGEN",
        "GHDX",
        "NVTA"
    ]
}